Alerte De Sécurité sur Trade Name: Load for Endo Gia Universal Stapler with Tri-Staple Technology. Technical Name: Clamps. ANVISA registration number: 10349000296. Class of Risk: III. Model Affected: EGIA45AMT; EGIA45AVM; EGIA45AXT; EGIA60AMT; EGIA60AXT; EGIA60AXT; EGIA45AMT; EGIA45AVM; EGIA60AMT; EGIA45AXT. Serial numbers affected: N7L1057KX; N7L0551KX; N7M0877KX; N8A0146KX; N8A0907KX; N8A0488KX; N7M0853KX; N7M0486KX; N7L0974KX; N8A0363KX; N7L0521KX; N7L1038KX

Selon Agência Nacional de Vigilância Sanitária (ANVISA), ce/cet/cette alerte de sécurité concerne un dispositif en/au/aux/à Brazil qui a été fabriqué par Auto Suture do Brasil Ltda; Covidien Llc.

Qu'est-ce que c'est?

Les alertes fournissent des informations importantes et des recommandations concernant les dispositifs médicaux. Le fait qu'une alerte soit émise ne signifie pas nécessairement qu'un dispositif soit dangereux. Les alertes de sécurité, qui sont envoyées tant aux travailleurs du secteur médical qu'aux utilisateurs de ces dispositifs, peuvent inclure des rappels. Elles peuvent être rédigées par des fabricants mais aussi par des autorités en charge de la santé.

En savoir plus sur les données ici
  • Type d'événement
    Safety alert
  • ID de l'événement
    2584
  • Date
    2018-06-04
  • Pays de l'événement
  • Source de l'événement
    ANVISA
  • URL de la source de l'événement
  • Notes / Alertes
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Notes supplémentaires dans les données
    Immediately discontinue use of the affected products (see affected affected fields and serial numbers affected by this alert and details in Attachment A of the Letter to Customer) Quarantine and return unused product codes and batches of listed items. used codes and batches of affected items must be returned as described in the Required Actions section of the Customer Letter.All unused product codes and batches of affected items must be returned to the company or distributors.If you wish to notify technical complaints and adverse events please use the following channels: Notivisa: Notices of adverse events (EA) and technical complaints (QT) for products subject to Sanitary Surveillance should be made through the NOTIVISA System (http://portal.anvisa.gov.br/notivisa). To access the System, you must register and select the Health Professional option, if you are a liberal professional or the Institution option o / Entity, if you are a professional of an institution / entity. System of Technovigilance: Patient or citizen can notify through the System of Tecnovigilância / SISTEC access through the link http://www.anvisa.gov.br/sistec/notificacaoavulsa/notificacaoavulsa1.asp - Date of identification of the problem by the company: 05/23/2018 - Notification date for Anvisa: 05/24/2018 The company holding the record of the affected product is responsible for contacting its clients in a timely manner to ensure the effectiveness of the ongoing Field Action. It stands out the joint responsibility of the distribution chain and use of health products in maintaining its quality, safety and efficacy, as well as the effectiveness of the Field Action, expressed by RDC 23/2012: (...) Art. 2 ° A holder of registration of health product is the holder of the registration / registration of health product with Anvisa. Single paragraph. The registration holder, as well as other agents involved from the production to the use of the product, or discarding it when applicable, are jointly and severally responsible for maintaining the quality, safety and efficacy of the health products to the final consumer. Art. 12 Distributors of health products shall forward to the registration holder, in a timely manner, the distribution map and other information requested for the notification and execution of field actions. (...)
  • Cause
    Due to the possibility of the device being improperly mounted at the factory, its use may result in failure to form a line of staples when the tissue is divided, leading to bleeding or leakage of luminal contents.
  • Action
    Field Action Code FAEndo Gia Tri-Staplesob company responsibility Auto Suture do Brasil Ltda. Gathering.

Manufacturer

  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    ANVSANVISA